Source:http://linkedlifedata.com/resource/pubmed/id/19011429
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-11-17
|
pubmed:abstractText |
Urinary incontinence and enuresis are well-known side effects of clozapine. However, clinical experience has shown that patients also suffer from diverse lower urinary tract symptoms (LUTS). The natural course of clozapine-related LUTS is unclear. Thus, a longitudinal follow-up study is needed. A total of 101 subjects who were taking clozapine initially participated. Their LUTS were evaluated using the International Prostate Symptom Score (IPSS), other questionnaires, and a medical records review. After 2 years, 87 of the original subjects could be contacted, and the status of their LUTS was re-evaluated. The average IPSS total was 7.4 +/- 5.9 at the initial evaluation. Although only 11 subjects (10.9%) reported actual incontinence, 42 subjects (41.6%) were found to have clinically significant LUTS (IPSS total score > or =8). No influencing factors could be found among the demographic and clinical variables. At the follow-up, the average IPSS total (7.9 +/- 6.0) and the percentage of subjects with clinically significant LUTS (43.7%) had both increased, although the change was not statistically significant. The prevalence of LUTS in clozapine-medicated patients was higher than in the general population of the same age. However, the prevalence of incontinence was only a quarter of that of LUTS. If clinicians focus only on incontinence, distress from LUTS will not receive appropriate attention. Furthermore, contrary to literature observations, clozapine-related LUTS did not remit easily but rather persisted even into the long-term maintenance phase. More concern should be directed at these troublesome and often neglected side effects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1533-712X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
618-24
|
pubmed:meshHeading |
pubmed-meshheading:19011429-Adult,
pubmed-meshheading:19011429-Antipsychotic Agents,
pubmed-meshheading:19011429-Clozapine,
pubmed-meshheading:19011429-Female,
pubmed-meshheading:19011429-Follow-Up Studies,
pubmed-meshheading:19011429-Humans,
pubmed-meshheading:19011429-Male,
pubmed-meshheading:19011429-Medical Records,
pubmed-meshheading:19011429-Prospective Studies,
pubmed-meshheading:19011429-Quality of Life,
pubmed-meshheading:19011429-Questionnaires,
pubmed-meshheading:19011429-Stress, Psychological,
pubmed-meshheading:19011429-Time Factors,
pubmed-meshheading:19011429-Urinary Incontinence,
pubmed-meshheading:19011429-Urination Disorders,
pubmed-meshheading:19011429-Young Adult
|
pubmed:year |
2008
|
pubmed:articleTitle |
A 2-year prospective follow-up study of lower urinary tract symptoms in patients treated with clozapine.
|
pubmed:affiliation |
Department of Psychiatry, Dongguk University College of Medicine, Gyeonggi, South Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|